Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis

被引：30
|
作者：
Daumerie, C
Vynckier, S
Caussin, J
Jadoul, M
Squifflet, JP
dePatoul, N
Wambersie, A
机构：
[1] CLIN UNIV ST LUC,DEPT RADIOTHERAPY,B-1200 BRUSSELS,BELGIUM
[2] CLIN UNIV ST LUC,DEPT RADIAT PROTECT,B-1200 BRUSSELS,BELGIUM
[3] CLIN UNIV ST LUC,DEPT NEPHROL,B-1200 BRUSSELS,BELGIUM
[4] CLIN UNIV ST LUC,DEPT ENDOCRINE SURG,B-1200 BRUSSELS,BELGIUM
来源：
THYROID | 1996年 / 6卷 / 04期
关键词：
D O I：
10.1089/thy.1996.6.301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To deliver optimal radioiodine activity in hemodialyzed patients with thyroid carcinoma, the behavior of radioiodine was followed during six treatments. During hemodialysis, blood activity decreases with a half-life of 3.4 +/- 0.5, (1SD) h. The whole body dose was calculated from the total activity determined during 10 days after I-131 administration. A reasonable strategy may consist in delivering 25% of the currently prescribed activity (925 MBq-25 mCi) and to perform the first dialysis session after 24 h to reduce total body irradiation.
引用
收藏
页码：301 / 304
页数：4
相关论文
共 50 条
  • [21] 30 mCi Radioiodine Treatment of Thyroid Carcinoma Patients in the post ESTIMABL Era
    Rusu, D.
    Fleury, V.
    Palpacuer, C.
    Le Thiec, M.
    Colombie, M.
    Kraeber-Bodere, F.
    Rousseau, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S324 - S324
  • [22] Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma
    Chung J.-K.
    Youn H.W.
    Kang J.H.
    Lee H.Y.
    Kang K.W.
    Nuclear Medicine and Molecular Imaging, 2010, 44 (1) : 4 - 14
  • [23] Challenges and strategies on radioiodine treatment for differentiated thyroid carcinoma
    Cheng, Lingxiao
    Liu, Min
    Ruan, Maomei
    Chen, Libo
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (01) : 23 - 32
  • [24] THE USE OF THIOURACIL IN THE TREATMENT OF METASTATIC CARCINOMA OF THE THYROID WITH RADIOIODINE
    RALL, JE
    MILLER, WN
    FOSTER, CG
    PEACOCK, WC
    RAWSON, RW
    JOURNAL OF CLINICAL ENDOCRINOLOGY, 1951, 11 (11): : 1273 - 1280
  • [25] Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma
    Yuan, Leilei
    Yang, Jigang
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (11-12): : 877 - 883
  • [26] Hemodialysis in patients requiring 131I treatment for thyroid carcinoma
    Fofi, Claudia
    Festuccia, Francescaromana
    Barberi, Simona
    Apponi, Francesca
    Chiacchiararelli, Laura
    Scopinaro, Francesco
    Punzo, Giorgio
    Mene, Paolo
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2013, 36 (06): : 439 - 443
  • [27] Can histopathological factors predict the outcome of radioiodine treatment in patients with differentiated thyroid carcinoma?
    Gao, Zairong
    Chang, Wei
    Zhang, Yongxue
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [28] The effect of radioiodine treatment on the development of second primary cancer in patients with differentiated thyroid carcinoma
    Fallahi, B.
    Beiki, D.
    Fard-Esfahani, A.
    Haghpanah, V.
    Eftekhari, M.
    Emami-Ardekani, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S319 - S319
  • [29] RADIOIODINE AND THYROID-CARCINOMA
    VALDES, M
    PINEDA, G
    REVISTA MEDICA DE CHILE, 1977, 105 (09) : 603 - 608
  • [30] RADIOIODINE THERAPY OF CARCINOMA OF THE THYROID
    MCCONNELL, R
    JOURNAL OF SURGICAL ONCOLOGY, 1981, 16 (03) : 251 - 254
12345